RhumbLine Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Sell
14,115
-803
-5% -$25.4K ﹤0.01% 2565
2025
Q4
$326K Sell
14,918
-2,863
-16% -$59.5K ﹤0.01% 2923
2025
Q3
$382K Sell
17,781
-10,217
-36% -$229K ﹤0.01% 2866
2025
Q2
$718K Buy
27,998
+11,615
+71% +$340K ﹤0.01% 2430
2025
Q1
$600K Sell
16,383
-4,331
-21% -$149K ﹤0.01% 2459
2024
Q4
$635K Sell
20,714
-551
-3% -$18.3K ﹤0.01% 2515
2024
Q3
$801K Buy
21,265
+985
+5% +$38K ﹤0.01% 2388
2024
Q2
$803K Buy
20,280
+48
+0.2% +$1.55K ﹤0.01% 2362
2024
Q1
$680K Buy
20,232
+377
+2% +$12.7K ﹤0.01% 2475
2023
Q4
$662K Sell
19,855
-329
-2% -$10.6K ﹤0.01% 2499
2023
Q3
$633K Sell
20,184
-4,054
-17% -$128K ﹤0.01% 2470
2023
Q2
$768K Sell
24,238
-2,002
-8% -$64.7K ﹤0.01% 2438
2023
Q1
$867K Buy
26,240
+3,184
+14% +$104K ﹤0.01% 2188
2022
Q4
$742K Buy
23,056
+561
+2% +$19.1K ﹤0.01% 2283
2022
Q3
$804K Buy
22,495
+6,553
+41% +$272K ﹤0.01% 2260
2022
Q2
$655K Buy
15,942
+1,837
+13% +$89.2K ﹤0.01% 2345
2022
Q1
$817K Sell
14,105
-1,301
-8% -$71.2K ﹤0.01% 2212
2021
Q4
$905K Sell
15,406
-190
-1% -$11.5K ﹤0.01% 2251
2021
Q3
$947K Buy
15,596
+598
+4% +$35.1K ﹤0.01% 2240
2021
Q2
$900K Buy
14,998
+2,000
+15% +$100K ﹤0.01% 2290
2021
Q1
$613K Sell
12,998
-800
-6% -$32.9K ﹤0.01% 2396
2020
Q4
$519K Buy
13,798
+800
+6% +$26.4K ﹤0.01% 2430
2020
Q3
$425K Sell
12,998
-4,102
-24% -$174K ﹤0.01% 2359
2020
Q2
$775K Buy
17,100
+4,094
+31% +$209K ﹤0.01% 2152
2020
Q1
$594K Buy
13,006
+63
+0.5% +$2.85K ﹤0.01% 2106
2019
Q4
$559K Buy
12,943
+445
+4% +$18.1K ﹤0.01% 2312
2019
Q3
$452K Buy
12,498
+590
+5% +$24.9K ﹤0.01% 2367
2019
Q2
$560K Sell
11,908
-1,385
-10% -$58.5K ﹤0.01% 2318
2019
Q1
$467K Sell
13,293
-135
-1% -$5.31K ﹤0.01% 2350
2018
Q4
$502K Buy
13,428
+4,191
+45% +$164K ﹤0.01% 2296
2018
Q3
$313K Hold
9,237
﹤0.01% 2495
2018
Q2
$230K Buy
9,237
+105
+1% +$2.92K ﹤0.01% 2669
2018
Q1
$273K Sell
9,132
-475
-5% -$15.9K ﹤0.01% 2480
2017
Q4
$308K Sell
9,607
-1,671
-15% -$53.8K ﹤0.01% 2458
2017
Q3
$336K Sell
11,278
-122
-1% -$3.34K ﹤0.01% 2506
2017
Q2
$266K Sell
11,400
-980
-8% -$22.8K ﹤0.01% 2618
2017
Q1
$271K Buy
12,380
+461
+4% +$10.4K ﹤0.01% 2551
2016
Q4
$269K Sell
11,919
-444
-4% -$10.7K ﹤0.01% 2539
2016
Q3
$283K Sell
12,363
-2,280
-16% -$50.9K ﹤0.01% 2514
2016
Q2
$313K Buy
14,643
+573
+4% +$18K ﹤0.01% 2503
2016
Q1
$483K Buy
14,070
+660
+5% +$17.4K ﹤0.01% 2246
2015
Q4
$369K Buy
13,410
+1,155
+9% +$31.6K ﹤0.01% 2445
2015
Q3
$366K Buy
12,255
+575
+5% +$18.8K ﹤0.01% 2427
2015
Q2
$492K Buy
+11,680
New +$551K ﹤0.01% 2341

Other funds holding ATEX

RhumbLine Advisers's ATEX Position: Q1 2026 in Review

RhumbLine Advisers reduced its Anterix (ATEX) stake by 5.4% in Q1 2026, selling an estimated $25.4K and leaving 14,115 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

RhumbLine Advisers first reported a position in ATEX in Q2 2015 and has held it in 44 quarters since. The position peaked at $947K in Q3 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • RhumbLine Advisers held 14,115 shares of Anterix worth $539K as of Q1 2026.
  • RhumbLine Advisers sold 803 Anterix shares in Q1 2026, an estimated $25.4K.
  • Anterix made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2565 holding.
  • RhumbLine Advisers first reported a position in Anterix in Q2 2015 and has held it in 44 quarters since.
  • RhumbLine Advisers's Anterix position peaked at $947K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.